CLINICAL_TRIALS
trial_result
· 2021-10-19
Clinical Trial Update: Tolerability and Immunogenicity of rBV A/B for the Production of BabyBIG® [Phase 2]
Summary
Phase 2 trial evaluating tolerability and immunogenicity of rBV A/B for producing BabyBIG® has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: California Department of Public Health | Conditions: Botulism | Phase 2 | Status: COMPLETED | Results posted: 2021-10-19